Coherus Biosciences | 营业利润



金融业
股票价格
USD
资产
USD 516.52M
现金及等价物
USD 103.35M
销售成本
USD 2.65M
流动资产
USD 460.96M
流动负债
USD 372.3M
债务
USD 294.93M
股息收益率
0
EBIT
USD -45.44M
EBITDA
USD -44.34M
员工
306
EPS每股收益
USD -0.35
股本和储备
USD 87.77M
销售毛利
USD 4.95M
债务利息支出
USD 2.15M
贷款资金
USD 294.85M
市值
USD 237.8M
净收入
USD -56.57M
营业费用
USD 53.03M
营业利润
USD -45.44M
普通股股本
USD 12K
税前利润
USD -47.4M
销售收入
USD 7.6M
销售和管理费用
USD 26.03M
股票
USD 2.05M
贸易债权人
USD 24.89M
应收帐款人
USD 62.44M


营业利润 更改 日
AbbVie USD 5.81B 1.23B 2025-12
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
Amarin USD -1.7M 8.47M 2025-09
Amgen USD 3.96B 464M 2025-12
Baxter International USD 201.2M 70.8M 2025-09
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -45.43M 3.13M 2025-03
Eli Lilly USD 8.99B 599.9M 2025-12
Fujifilm JPY 89.96B 6.77B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 6.24B 318M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Pacira USD 13.15M 2.92M 2025-09
Perrigo USD 93.4M 37.8M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09
Xencor USD -47.52M 14.35M 2025-09
Zoetis USD 936M 63M 2025-09


Coherus Biosciences 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.